The North America Neurovascular Catheters Market would witness market growth of 6.3% CAGR during the forecast period (2023-2029).
The market potential for products and services catering to the geriatric population (those aged 65 years or above) is expanding globally due to advancements in healthcare and heightened awareness of health concerns among seniors. In addition, the forecast period will witness growth in the neurovascular catheter market due to the rise in age-related neurological disorders. A multi-lumen catheter is a medical device that features several internal channels, or lumens, within a single catheter.
Each lumen has the capability to be linked to a separate intravenous infusion, and typically the fluid will exit at a slightly varied location along the catheter. The expansion of the multi-lumen catheter market is anticipated during the forecast period owing to the increasing prevalence of neurovascular disorders like ischemic stroke, stenosis, brain aneurysm, and other ailments, along with advances in technology in neurovascular catheters. The anticipated growth of the studied segment is attributed to the increase in multi-lumen catheter product launches and growing research and development over the forecast period.
The market is being driven by a variety of factors, including the increasing incidence of neurological conditions such as brain stroke and aneurysms, the spread of unhealthy lifestyles, growing awareness among the general population about neurological treatment, rising levels of disposable income, and the introduction of new products by major market players.
In the United States, over 10,000 individuals turn 65 every day. In 2019, 54.1 million people in the United States were 65 years of age or older. More than one in seven Americans and they made up 16% of the population, represented. Since 2009, there has been a 36% increase in elderly Americans, which amounts to 14.4 million more individuals. In comparison, the population under 65 has only experienced a 3% increase. The demographic of Americans aged 45 to 64, who will reach the age of 65 within the next two decades, experienced a 4% growth from 80.3 million to 83.3 million between 2009 and 2019.
The population of Americans aged 60 and over has increased by 34%, from 55.7 million to 74.6 million. There were 24.1 million males and 30 million women over the age of 65 in 2019. Future projections indicate that the senior population will continue to increase dramatically. Hence, the aging population in the region is expected to surge the demand for neurovascular catheters as the geriatric population is more prone to get neurovascular-related illnesses like embolic stroke, which require the use of these catheters, thereby propelling the market growth in North America.
The US market dominated the North America Neurovascular Catheters Market by Country in 2022; thereby, achieving a market value of $1,249.2 million by 2029. The Canada market is poised to grow at a CAGR of 8.7% during (2023 - 2029). Additionally, The Mexico market would witness a CAGR of 7.8% during (2023 - 2029).
Based on Type, the market is segmented into Embolization Catheters, Access Catheters, Balloon Catheters, Microcatheters and Others. Based on End-Use, the market is segmented into Hospitals, Clinics, Ambulatory Surgical Centers and Diagnostic Centers. Based on Application, the market is segmented into Brain Aneurysm, Embolic Stroke, Arteriovenous Malformations and Hydrolysate. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Neurovascular Catheters Market is Projected to reach USD 4.6 Billion by 2029, at a CAGR of 6.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Terumo Corporation, Integer Holdings Corporation, Penumbra, Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), Integra LifeSciences Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, RAUMEDIC AG (REHAU Industries SE & Co. KG).
Scope of the Study
Market Segments Covered in the Report:
By Type
- Embolization Catheters
- Access Catheters
- Balloon Catheters
- Microcatheters
- Others
By End Use
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
By Application
- Brain Aneurysm
- Embolic Stroke
- Arteriovenous Malformations
- Hydrolysate
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Stryker Corporation
- Terumo Corporation
- Integer Holdings Corporation
- Penumbra, Inc.
- Johnson & Johnson (Johnson & Johnson Services, Inc.)
- Integra LifeSciences Corporation
- Acandis GmbH
- Spiegelberg GmbH & Co. KG
- RAUMEDIC AG (REHAU Industries SE & Co. KG)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Neurovascular Catheters Market, by Type
1.4.2 North America Neurovascular Catheters Market, by End Use
1.4.3 North America Neurovascular Catheters Market, by Application
1.4.4 North America Neurovascular Catheters Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Trials and Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
Chapter 4. North America Neurovascular Catheters Market by Type
4.1 North America Embolization Catheters Market by Country
4.2 North America Access Catheters Market by Country
4.3 North America Balloon Catheters Market by Country
4.4 North America Microcatheters Market by Country
4.5 North America Others Market by Country
Chapter 5. North America Neurovascular Catheters Market by End-use
5.1 North America Hospitals Market by Country
5.2 North America Clinics Market by Country
5.3 North America Ambulatory Surgical Centers Market by Country
5.4 North America Diagnostic Centers Market by Country
Chapter 6. North America Neurovascular Catheters Market by Application
6.1 North America Brain Aneurysm Market by Country
6.2 North America Embolic Stroke Market by Country
6.3 North America Arteriovenous Malformations Market by Country
6.4 North America Hydrolysate Market by Country
Chapter 7. North America Neurovascular Catheters Market by Country
7.1 US Neurovascular Catheters Market
7.1.1 US Neurovascular Catheters Market by Type
7.1.2 US Neurovascular Catheters Market by End-use
7.1.3 US Neurovascular Catheters Market by Application
7.2 Canada Neurovascular Catheters Market
7.2.1 Canada Neurovascular Catheters Market by Type
7.2.2 Canada Neurovascular Catheters Market by End-use
7.2.3 Canada Neurovascular Catheters Market by Application
7.3 Mexico Neurovascular Catheters Market
7.3.1 Mexico Neurovascular Catheters Market by Type
7.3.2 Mexico Neurovascular Catheters Market by End-use
7.3.3 Mexico Neurovascular Catheters Market by Application
7.4 Rest of North America Neurovascular Catheters Market
7.4.1 Rest of North America Neurovascular Catheters Market by Type
7.4.2 Rest of North America Neurovascular Catheters Market by End-use
7.4.3 Rest of North America Neurovascular Catheters Market by Application
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals and Trials:
8.1.6 SWOT Analysis
8.2 Johnson & Johnson (Johnson & Johnson Services, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 Penumbra, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.5.3 Approvals and Trials:
8.4 Integer Holdings Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.5.2 Geographical Expansions:
8.5 Terumo Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Regional Analysis
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Stryker Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Approvals and Trials:
8.6.5.2 Geographical Expansions:
8.7 Integra LifeSciences Holdings Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 Acandis GmbH
8.8.1 Company Overview
8.9 Spiegelberg GmbH & Co. KG.
8.9.1 Company Overview
8.10. RAUMEDIC AG (REHAU Industries SE & Co. KG)
8.10.1 Company Overview
TABLE 1 North America Neurovascular Catheters Market, 2019 - 2022, USD Million
TABLE 2 North America Neurovascular Catheters Market, 2023 - 2029, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Neurovascular Catheters Market
TABLE 4 Product Launches And Product Expansions– Neurovascular Catheters Market
TABLE 5 Acquisition and Mergers– Neurovascular Catheters Market
TABLE 6 geographical expansion – Neurovascular Catheters Market
TABLE 7 Trials and approvals – Neurovascular Catheters Market
TABLE 8 North America Neurovascular Catheters Market by Type, 2019 - 2022, USD Million
TABLE 9 North America Neurovascular Catheters Market by Type, 2023 - 2029, USD Million
TABLE 10 North America Embolization Catheters Market by Country, 2019 - 2022, USD Million
TABLE 11 North America Embolization Catheters Market by Country, 2023 - 2029, USD Million
TABLE 12 North America Access Catheters Market by Country, 2019 - 2022, USD Million
TABLE 13 North America Access Catheters Market by Country, 2023 - 2029, USD Million
TABLE 14 North America Balloon Catheters Market by Country, 2019 - 2022, USD Million
TABLE 15 North America Balloon Catheters Market by Country, 2023 - 2029, USD Million
TABLE 16 North America Microcatheters Market by Country, 2019 - 2022, USD Million
TABLE 17 North America Microcatheters Market by Country, 2023 - 2029, USD Million
TABLE 18 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 19 North America Others Market by Country, 2023 - 2029, USD Million
TABLE 20 North America Neurovascular Catheters Market by End-use, 2019 - 2022, USD Million
TABLE 21 North America Neurovascular Catheters Market by End-use, 2023 - 2029, USD Million
TABLE 22 North America Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 23 North America Hospitals Market by Country, 2023 - 2029, USD Million
TABLE 24 North America Clinics Market by Country, 2019 - 2022, USD Million
TABLE 25 North America Clinics Market by Country, 2023 - 2029, USD Million
TABLE 26 North America Ambulatory Surgical Centers Market by Country, 2019 - 2022, USD Million
TABLE 27 North America Ambulatory Surgical Centers Market by Country, 2023 - 2029, USD Million
TABLE 28 North America Diagnostic Centers Market by Country, 2019 - 2022, USD Million
TABLE 29 North America Diagnostic Centers Market by Country, 2023 - 2029, USD Million
TABLE 30 North America Neurovascular Catheters Market by Application, 2019 - 2022, USD Million
TABLE 31 North America Neurovascular Catheters Market by Application, 2023 - 2029, USD Million
TABLE 32 North America Brain Aneurysm Market by Country, 2019 - 2022, USD Million
TABLE 33 North America Brain Aneurysm Market by Country, 2023 - 2029, USD Million
TABLE 34 North America Embolic Stroke Market by Country, 2019 - 2022, USD Million
TABLE 35 North America Embolic Stroke Market by Country, 2023 - 2029, USD Million
TABLE 36 North America Arteriovenous Malformations Market by Country, 2019 - 2022, USD Million
TABLE 37 North America Arteriovenous Malformations Market by Country, 2023 - 2029, USD Million
TABLE 38 North America Hydrolysate Market by Country, 2019 - 2022, USD Million
TABLE 39 North America Hydrolysate Market by Country, 2023 - 2029, USD Million
TABLE 40 North America Neurovascular Catheters Market by Country, 2019 - 2022, USD Million
TABLE 41 North America Neurovascular Catheters Market by Country, 2023 - 2029, USD Million
TABLE 42 US Neurovascular Catheters Market, 2019 - 2022, USD Million
TABLE 43 US Neurovascular Catheters Market, 2023 - 2029, USD Million
TABLE 44 US Neurovascular Catheters Market by Type, 2019 - 2022, USD Million
TABLE 45 US Neurovascular Catheters Market by Type, 2023 - 2029, USD Million
TABLE 46 US Neurovascular Catheters Market by End-use, 2019 - 2022, USD Million
TABLE 47 US Neurovascular Catheters Market by End-use, 2023 - 2029, USD Million
TABLE 48 US Neurovascular Catheters Market by Application, 2019 - 2022, USD Million
TABLE 49 US Neurovascular Catheters Market by Application, 2023 - 2029, USD Million
TABLE 50 Canada Neurovascular Catheters Market, 2019 - 2022, USD Million
TABLE 51 Canada Neurovascular Catheters Market, 2023 - 2029, USD Million
TABLE 52 Canada Neurovascular Catheters Market by Type, 2019 - 2022, USD Million
TABLE 53 Canada Neurovascular Catheters Market by Type, 2023 - 2029, USD Million
TABLE 54 Canada Neurovascular Catheters Market by End-use, 2019 - 2022, USD Million
TABLE 55 Canada Neurovascular Catheters Market by End-use, 2023 - 2029, USD Million
TABLE 56 Canada Neurovascular Catheters Market by Application, 2019 - 2022, USD Million
TABLE 57 Canada Neurovascular Catheters Market by Application, 2023 - 2029, USD Million
TABLE 58 Mexico Neurovascular Catheters Market, 2019 - 2022, USD Million
TABLE 59 Mexico Neurovascular Catheters Market, 2023 - 2029, USD Million
TABLE 60 Mexico Neurovascular Catheters Market by Type, 2019 - 2022, USD Million
TABLE 61 Mexico Neurovascular Catheters Market by Type, 2023 - 2029, USD Million
TABLE 62 Mexico Neurovascular Catheters Market by End-use, 2019 - 2022, USD Million
TABLE 63 Mexico Neurovascular Catheters Market by End-use, 2023 - 2029, USD Million
TABLE 64 Mexico Neurovascular Catheters Market by Application, 2019 - 2022, USD Million
TABLE 65 Mexico Neurovascular Catheters Market by Application, 2023 - 2029, USD Million
TABLE 66 Rest of North America Neurovascular Catheters Market, 2019 - 2022, USD Million
TABLE 67 Rest of North America Neurovascular Catheters Market, 2023 - 2029, USD Million
TABLE 68 Rest of North America Neurovascular Catheters Market by Type, 2019 - 2022, USD Million
TABLE 69 Rest of North America Neurovascular Catheters Market by Type, 2023 - 2029, USD Million
TABLE 70 Rest of North America Neurovascular Catheters Market by End-use, 2019 - 2022, USD Million
TABLE 71 Rest of North America Neurovascular Catheters Market by End-use, 2023 - 2029, USD Million
TABLE 72 Rest of North America Neurovascular Catheters Market by Application, 2019 - 2022, USD Million
TABLE 73 Rest of North America Neurovascular Catheters Market by Application, 2023 - 2029, USD Million
TABLE 74 Key Information – Medtronic PLC
TABLE 75 Key Information – Johnson & Johnson
TABLE 76 Key Information – Penumbra, Inc.
TABLE 77 Key Information – Integer Holdings Corporation
TABLE 78 Key Information – Terumo Corporation
TABLE 79 key Information – Stryker Corporation
TABLE 80 Key Information – Integra LifeSciences Holdings Corporation
TABLE 81 Key Information – Acandis GmbH
TABLE 82 Key Information – Spiegelberg GmbH & Co. KG
TABLE 83 Key Information – RAUMEDIC AG
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Swot analysis: Medtronic plc
FIG 5 SWOT analysis: Johnson & Johnson
FIG 6 Recent strategies and developments: Penumbra, Inc.
FIG 7 Recent strategies and developments: Integer Holdings Corporation